Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China · Delayed Price · Currency is CNY 2.580
-0.060 (-2.27%)
Jun 11, 2026, 3:04 PM CST
Huaren Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,121 | 3,724 | 4,161 | 4,989 | 5,013 | 5,675 | |
Market Cap Growth | -14.01% | -10.51% | -16.59% | -0.47% | -11.67% | 1.48% |
Enterprise Value | 3,910 | 4,425 | 5,100 | 6,192 | 6,679 | 7,116 |
Last Close Price | 2.64 | 3.15 | 3.52 | 4.19 | 4.19 | 4.72 |
PE Ratio | - | - | - | 26.53 | 27.73 | 43.52 |
Forward PE | - | 41.18 | 41.18 | 41.18 | 41.18 | 41.18 |
PS Ratio | 2.35 | 2.82 | 3.08 | 3.05 | 3.10 | 3.64 |
PB Ratio | 3.37 | 4.10 | 3.03 | 1.80 | 1.93 | 2.32 |
P/TBV Ratio | 8.49 | 10.77 | 15.62 | 3.21 | 3.65 | 4.82 |
P/FCF Ratio | 11.15 | 10.91 | 13.98 | 19.21 | 28.54 | - |
P/OCF Ratio | 10.14 | 9.54 | 12.91 | 16.33 | 23.00 | - |
EV/Sales Ratio | 2.94 | 3.35 | 3.77 | 3.78 | 4.12 | 4.56 |
EV/EBITDA Ratio | 17.33 | 19.40 | 20.57 | 13.15 | 16.99 | 19.71 |
EV/EBIT Ratio | 32.27 | 36.47 | 39.22 | 17.95 | 27.31 | 31.40 |
EV/FCF Ratio | 13.97 | 12.97 | 17.14 | 23.84 | 38.03 | - |
Debt / Equity Ratio | 0.98 | 1.02 | 0.93 | 0.56 | 0.64 | 0.75 |
Debt / EBITDA Ratio | 4.00 | 4.07 | 5.14 | 3.32 | 4.24 | 5.09 |
Debt / FCF Ratio | 3.23 | 2.73 | 4.29 | 6.02 | 9.52 | - |
Net Debt / Equity Ratio | 0.77 | 0.87 | 0.81 | 0.48 | 0.56 | 0.58 |
Net Debt / EBITDA Ratio | 3.18 | 3.47 | 4.49 | 2.83 | 3.69 | 3.94 |
Net Debt / FCF Ratio | 2.56 | 2.32 | 3.74 | 5.13 | 8.25 | -2.35 |
Asset Turnover | 0.43 | 0.43 | 0.32 | 0.32 | 0.30 | 0.35 |
Inventory Turnover | 3.33 | 3.09 | 2.71 | 3.13 | 3.41 | 3.00 |
Quick Ratio | 0.59 | 0.49 | 0.54 | 1.58 | 1.18 | 1.05 |
Current Ratio | 0.82 | 0.67 | 0.77 | 1.84 | 1.35 | 1.20 |
Return on Equity (ROE) | -39.64% | -40.24% | -65.84% | 7.21% | 7.19% | 5.62% |
Return on Assets (ROA) | 2.43% | 2.47% | 1.89% | 4.17% | 2.83% | 3.13% |
Return on Invested Capital (ROIC) | 7.25% | 5.79% | 3.95% | 7.10% | 5.44% | 6.22% |
Return on Capital Employed (ROCE) | 8.40% | 9.90% | 6.90% | 9.40% | 7.80% | 7.40% |
Earnings Yield | -14.83% | -12.43% | -32.88% | 3.77% | 3.61% | 2.30% |
FCF Yield | 8.96% | 9.16% | 7.15% | 5.21% | 3.50% | -10.69% |
Dividend Yield | - | - | - | 0.50% | 0.50% | 0.38% |
Payout Ratio | - | - | - | 45.81% | 49.44% | 54.73% |
Buyback Yield / Dilution | -0.14% | 0.01% | -0.01% | -0.04% | 0.33% | -0.23% |
Total Shareholder Return | -0.14% | 0.01% | -0.01% | 0.46% | 0.83% | 0.15% |